A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the changes were more pronounced in women, researchers reported at ENDO 2025.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious conditions such as dementia and stroke, a new study has indicated. The research ...

In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, Chinese obese individuals can maintain significant ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

Tirzepatide helps obese adults lose over 15% of body weight in 52 weeks—and retain much of it even six months after stopping ...

Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

Check your insurance plan to be sure, but providers don’t often cover tirzepatide for weight loss. If they do, there might be some requirements you need to meet or copays and deductibles, so you ...

Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...

When it comes to weight loss, we’re all after a magic bullet, a simple, stress-free way of shedding the excess pounds. And so for millions around the world, the arrival of the so-called GLP-1 ...